Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/19/2000CA2367494A1 Combinations of gaba analogs and tricyclic compounds to treat depression
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2364690A1 Novel transduction molecules and methods for using same
10/19/2000CA2364675A1 Methods of inducing cancer cell death and tumor regression
10/19/2000CA2364659A1 A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate
10/19/2000CA2364577A1 Regulation of repressor genes using nucleic acid molecules
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2362026A1 Method for the treatment of incontinence
10/19/2000CA2306039A1 Hcv combination therapy
10/19/2000CA2305942A1 Composition containing at least one aromatic bicyclic compound and at least one 2-alkyl alcan-1-ol or an ester, and its uses
10/18/2000EP1044987A2 Gapped 2'-modified oligonucleotides
10/18/2000EP1044977A1 Camptothecin derivatives having antitumor activity
10/18/2000EP1044975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044966A1 (Poly)thia-alkyne compounds and their derivatives, compositions containing them and their use
10/18/2000EP1044691A2 Use of glycosaminoglycan lipid conjugates for inducing osteogenesis
10/18/2000EP1044689A1 Solid iodophor preparations and process for producing the same
10/18/2000EP1044688A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
10/18/2000EP1044687A1 Powders containing tocotrienols, process for producing the same and tablets prepared by compression molding the same
10/18/2000EP1044686A1 Alcoholic coloured chlorhexidine solution and its manufacturing process
10/18/2000EP1044685A2 Farnesol derivatives for morphological transition control over dimorphic fungi
10/18/2000EP1044680A1 Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
10/18/2000EP1044676A2 Oily material composition
10/18/2000EP1044277A2 Recombinant, active caspases and uses thereof
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044221A1 Novel pectic polysaccharides purified from angelica gigas nakai and purification method and use as immuno-stimulating agent thereof
10/18/2000EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044208A1 Erythromycin derivatives
10/18/2000EP1044207A1 Novel macrolides
10/18/2000EP1044206A1 Prodrugs of naaladase inhibitors
10/18/2000EP1044203A1 3'-epimeric k-252a derivatives
10/18/2000EP1044202A1 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides
10/18/2000EP1044201A1 3-substituted adenines via2-thioxanthines
10/18/2000EP1044200A1 Preparation of terazosin hydrochloride dihydrate
10/18/2000EP1044199A1 Heterocyclic topoisomerase poisons
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044194A1 Receptor with an affinity for compounds of the oxazoline class
10/18/2000EP1044189A1 Aryl fused azapolycyclic compounds
10/18/2000EP1044187A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia
10/18/2000EP1044186A1 Substituted 2-benzylamino-2-phenyl-acetamide compounds
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1044023A1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia
10/18/2000EP1044021A1 Enhanced transport using membrane disruptive agents
10/18/2000EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/18/2000EP1044017A1 Supplement for dialysis patients
10/18/2000EP1044009A2 Methods and compositions employing red rice fermentation products
10/18/2000EP1044008A1 Use of aliphatic polyamines for reducing oxalate
10/18/2000EP1044007A1 The use of mannose for combating protein loss enteropathy
10/18/2000EP1044006A1 Use of an antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection
10/18/2000EP1044005A1 1,2,4-benzotriazine oxides formulations
10/18/2000EP1044004A1 A2a adenosine receptor agonists in combination with a type iv phosphodiesterase inhibitors
10/18/2000EP1044003A1 Compositions and methods for use in ischemia-reperfusion and endotoxin-related tissue injury
10/18/2000EP1044002A1 Methods for treatment of disorders of cardiac contractility
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP1044000A1 Combination therapy for the treatment of aids
10/18/2000EP1043999A1 Novel substituted pyridine compounds useful as modulators of acetylcholine receptors
10/18/2000EP1043998A1 USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
10/18/2000EP1043997A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
10/18/2000EP1043996A2 Treatment of dyskinesias
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043994A1 Method for treating multiple sclerosis
10/18/2000EP1043993A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
10/18/2000EP1043992A2 $i(R)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE
10/18/2000EP1043991A1 Treatment for alzheimer's disease
10/18/2000EP1043990A1 Pyronin antibacterials, process and novel intermediates thereto
10/18/2000EP1043989A1 Use of mek1 inhibitors as protective agents against damage due to ischemia
10/18/2000EP1043988A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
10/18/2000EP1043987A1 Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host
10/18/2000EP1043986A2 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
10/18/2000EP1043984A1 Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer
10/18/2000EP1043983A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
10/18/2000EP1043982A2 Lipase inhibiting polymers
10/18/2000EP1043981A2 Fat-binding polymers combined with lipase inhibitors
10/18/2000EP1043980A2 Method of reducing craving in mammals
10/18/2000EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000EP1043975A1 Magnetically responsive composition
10/18/2000EP1043973A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
10/18/2000EP1043941A1 Revitalisation formulation
10/18/2000EP1043930A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
10/18/2000EP1043928A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells
10/18/2000EP0988274A4 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/18/2000EP0921793B1 Solid, non-deliquescent formulations of sodium valproate
10/18/2000EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
10/18/2000EP0823901B1 Quinazoline derivative
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000EP0684826B1 Ecdysones used to improve productivity of ruminants
10/18/2000EP0648112B1 Precipitation of one or more active compounds in situ
10/18/2000EP0633886B1 Pharmaceutically active bicyclic-heterocyclic amines
10/18/2000EP0603251B1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
10/18/2000CN1270594A Process for producing 3-cephem compounds
10/18/2000CN1270592A Spiroazabicyclic heterocyclic compounds
1 ... 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 6241 6242 6243 6244 6245 6246 ... 7860